Details of the Drug
- Generic Name:
- feh-DRAH-tih-nib HY-droh-KLOR-ide
- Drug Type:
- Kinase inhibitor
- How the Drug is Given:
Indications and Usage
Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).
Side effects needing medical attention
Diarrhea, nausea, anemia, and vomiting.